These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8880057)

  • 21. The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of beta-carotene in healthy volunteers.
    Zhi J; Melia AT; Koss-Twardy SG; Arora S; Patel IH
    J Clin Pharmacol; 1996 Feb; 36(2):152-9. PubMed ID: 8852391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Gottdiener JS; Reda DJ; Massie BM; Materson BJ; Williams DW; Anderson RJ
    Circulation; 1997 Apr; 95(8):2007-14. PubMed ID: 9133508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study.
    Wójcicki J; Wojciechowski G; Wójcicki M; Kostyrka R; Sterna R; Gawronska-Szklarz B; Pawlik A; Drozdzik M; Kozlowski K
    Eur J Clin Pharmacol; 2000 Apr; 56(1):75-9. PubMed ID: 10853882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists.
    Zannad F; Matzinger A; Larché J
    Am J Hypertens; 1996 Jul; 9(7):633-43. PubMed ID: 8806975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Captopril compared to atenolol in mild to moderate hypertension in a randomized double-blind controlled trial.
    Havinga TK; ten Berge BS; May JF; Schuurman FH; van der Veur E; Wesseling H
    Neth J Med; 1991 Feb; 38(1-2):13-7. PubMed ID: 2030804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nifedipine/atenolol interactions in gastrointestinal absorption and biotransformation.
    Iglesias R; Taboada C; Souto C; Martínez-Pacheco R; Gómez-Amoza JL; Concheiro A
    Pharmazie; 1997 Sep; 52(9):717-20. PubMed ID: 9347573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence of two tablet formulations of atenolol after single oral administration in healthy volunteers.
    Niopas I; Daftsios AC; Xanthakis I; Nikolaidis N; Njau SN
    Arzneimittelforschung; 2000 Mar; 50(3):243-7. PubMed ID: 10758775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of reduced dietary fat absorption induced by orlistat on the pharmacokinetics of digoxin in healthy volunteers.
    Melia AT; Zhi J; Koss-Twardy SG; Min BH; Smith BL; Freundlich NL; Arora S; Passe SM
    J Clin Pharmacol; 1995 Aug; 35(8):840-3. PubMed ID: 8522642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of losartan, captopril, and furosemide in preventing nitrate tolerance and improving control of unstable angina pectoris.
    Cotter G; Metzkor-Cotter E; Kaluski E; Blatt A; Litinsky I; Baumohl Y; Moshkovitz Y; Vered Z; Zaidenstein R; Golik A
    Am J Cardiol; 1998 Nov; 82(9):1024-9. PubMed ID: 9817475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No sex-related pharmacokinetic and pharmacodynamic differences of captopril.
    Massana E; Barbanoj MJ; Moros C; Morte A; Gich I; Jané F
    Pharmacol Res; 1997 Jul; 36(1):41-7. PubMed ID: 9368913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of the lipase inhibitor orlistat with ethanol in healthy volunteers.
    Melia AT; Zhi J; Zelasko R; Hartmann D; Güzelhan C; Guerciolini R; Odink J
    Eur J Clin Pharmacol; 1998; 54(9-10):773-7. PubMed ID: 9923583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
    Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
    Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of 21 antihypertensive drugs in serum using UHPLC-MS/MS.
    Gundersen POM; Helland A; Spigset O; Hegstad S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():84-93. PubMed ID: 29783197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjects.
    Bolbrinker J; Huber M; Scholze J; Kreutz R
    Fundam Clin Pharmacol; 2009 Dec; 23(6):767-74. PubMed ID: 19659504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic interactions of nifedipine and quinidine.
    Hippius M; Henschel L; Sigusch H; Tepper J; Brendel E; Hoffmann A
    Pharmazie; 1995 Sep; 50(9):613-6. PubMed ID: 7480098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of captopril, hydralazine and nifedipine as third drug in hypertensive patients.
    Bevan EG; Pringle SD; Waller PC; Herrick AL; Findlay JG; Murray GD; Carmichael HA; Reid JL; Weir RJ; Lorimer AR
    J Hum Hypertens; 1993 Feb; 7(1):83-8. PubMed ID: 8095558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of tablets for controlled joint release of nifedipine and atenolol.
    Iglesias R; Taboada C; Souto C; Martínez-Pacheco R; Gómez-Amoza JL; Concheiro A
    Drug Dev Ind Pharm; 1998 Sep; 24(9):835-40. PubMed ID: 9876534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Zhi J; Melia AT; Guerciolini R; Koss-Twardy SG; Passe SM; Rakhit A; Sadowski JA
    J Clin Pharmacol; 1996 Jul; 36(7):659-66. PubMed ID: 8844450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.